MYC and HIF-1α are known to cooperatively activate glycolysis to generate adequate energy for tumor cells, resulting in chemo-resistance through the upregulation of many genes relevant to glucose metabolism [27, 34, 35]. The gene discussed is HIF1A; the disease is neoplasm.